Brief: Gen Ilac
Dec 22 (Reuters) - GEN ILAC VE SAGLIK GENIL.IS :
* SIGNS DEAL TO ACQUIRE 10.75% SHARES IN U.S.-BASED MEDICAL
COMPANY STIMUSIL INC AT $747,496 BY JOINING CAPITAL INCREASE
Source text for Eikon: urn:newsml:reuters.com:*:nIKA9m4P7v
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira